Bruton’s tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment
Crossref DOI link: https://doi.org/10.1007/s00262-021-02908-5
Published Online: 2021-04-05
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Good, Logan
Benner, Brooke
Carson, William E. http://orcid.org/0000-0001-7024-7533
Funding for this research was provided by:
National Institutes of Health (P01CA95426, T32CA90338-27)
Text and Data Mining valid from 2021-04-05
Version of Record valid from 2021-04-05
Article History
Received: 12 October 2020
Accepted: 2 March 2021
First Online: 5 April 2021